CBD for Symptoms of Psychosis in Parkinson's Patients

King's College London receives charitable donation from Parkinson's UK to begin a first-of-its-kind clinical trial to study the effects of CBD on psychosis symptoms in patients with early-stage Parkinson's disease. Parkinson's UK, Europe's largest charitable institution for Parkinson's research, announced this week that they will be funding the first-ever clinical trial to determine if cannabidiol (CBD) is a safe and effective treatment for symptoms of psychosis associated with the disease. Th...